Fed. Circ.'s Latest Guidance On Method-Of-Treatment Claims
On April 13, 2018, the Federal Circuit held that a Hatch-Waxman plaintiff's patent claims concerning methods of treating schizophrenia were not directed to a patent-ineligible concept under step one of the...To view the full article, register now.
Already a subscriber? Click here to view full article